

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 5.72071002 |
| 2 | NADH metabolic process (GO:0006734) | 5.57923230 |
| 3 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.27302805 |
| 4 | respiratory chain complex IV assembly (GO:0008535) | 5.10621816 |
| 5 | cytochrome complex assembly (GO:0017004) | 4.90200172 |
| 6 | protein complex biogenesis (GO:0070271) | 4.84989337 |
| 7 | succinate metabolic process (GO:0006105) | 4.62796086 |
| 8 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.60349982 |
| 9 | oxaloacetate metabolic process (GO:0006107) | 4.49296161 |
| 10 | oxidative phosphorylation (GO:0006119) | 4.47849208 |
| 11 | regulation of mitochondrial translation (GO:0070129) | 4.24864519 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 4.17437329 |
| 13 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.14516112 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.13793701 |
| 15 | behavioral response to nicotine (GO:0035095) | 4.09647349 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.07626770 |
| 17 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.07294565 |
| 18 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.07294565 |
| 19 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.06791409 |
| 20 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.05093011 |
| 21 | piRNA metabolic process (GO:0034587) | 3.97398602 |
| 22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.94048202 |
| 23 | adenine nucleotide transport (GO:0051503) | 3.91648050 |
| 24 | 2-oxoglutarate metabolic process (GO:0006103) | 3.91519260 |
| 25 | mitochondrial RNA metabolic process (GO:0000959) | 3.87413728 |
| 26 | purine ribonucleotide transport (GO:0015868) | 3.86686043 |
| 27 | base-excision repair, AP site formation (GO:0006285) | 3.84365575 |
| 28 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.82366081 |
| 29 | regulation of female receptivity (GO:0045924) | 3.81260994 |
| 30 | regulation of cofactor metabolic process (GO:0051193) | 3.80646494 |
| 31 | regulation of coenzyme metabolic process (GO:0051196) | 3.80646494 |
| 32 | axoneme assembly (GO:0035082) | 3.78079851 |
| 33 | DNA methylation involved in gamete generation (GO:0043046) | 3.75006057 |
| 34 | regulation of cellular respiration (GO:0043457) | 3.74197073 |
| 35 | purine nucleotide transport (GO:0015865) | 3.70857567 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 3.68916866 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.68299549 |
| 38 | female mating behavior (GO:0060180) | 3.67174805 |
| 39 | protein deneddylation (GO:0000338) | 3.67145244 |
| 40 | regulation of oxidative phosphorylation (GO:0002082) | 3.66204218 |
| 41 | cullin deneddylation (GO:0010388) | 3.65938032 |
| 42 | metallo-sulfur cluster assembly (GO:0031163) | 3.63172509 |
| 43 | iron-sulfur cluster assembly (GO:0016226) | 3.63172509 |
| 44 | intracellular protein transmembrane import (GO:0044743) | 3.57914376 |
| 45 | respiratory electron transport chain (GO:0022904) | 3.56532001 |
| 46 | carnitine metabolic process (GO:0009437) | 3.52343704 |
| 47 | electron transport chain (GO:0022900) | 3.49108739 |
| 48 | neuron cell-cell adhesion (GO:0007158) | 3.48839606 |
| 49 | cell communication by electrical coupling (GO:0010644) | 3.48067924 |
| 50 | synaptic vesicle exocytosis (GO:0016079) | 3.45371499 |
| 51 | regulation of cilium movement (GO:0003352) | 3.42155939 |
| 52 | lysine catabolic process (GO:0006554) | 3.32547050 |
| 53 | lysine metabolic process (GO:0006553) | 3.32547050 |
| 54 | ubiquinone biosynthetic process (GO:0006744) | 3.32153644 |
| 55 | quinone biosynthetic process (GO:1901663) | 3.32153644 |
| 56 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.31880551 |
| 57 | platelet dense granule organization (GO:0060155) | 3.27250128 |
| 58 | L-fucose catabolic process (GO:0042355) | 3.23605222 |
| 59 | fucose catabolic process (GO:0019317) | 3.23605222 |
| 60 | L-fucose metabolic process (GO:0042354) | 3.23605222 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.23321737 |
| 62 | ATP biosynthetic process (GO:0006754) | 3.21152896 |
| 63 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20661051 |
| 64 | pseudouridine synthesis (GO:0001522) | 3.20507877 |
| 65 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.20278247 |
| 66 | protein polyglutamylation (GO:0018095) | 3.20050353 |
| 67 | dicarboxylic acid catabolic process (GO:0043649) | 3.19747119 |
| 68 | vocalization behavior (GO:0071625) | 3.18320359 |
| 69 | glutathione biosynthetic process (GO:0006750) | 3.16765486 |
| 70 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.15439930 |
| 71 | glutamate secretion (GO:0014047) | 3.15280015 |
| 72 | ATP synthesis coupled proton transport (GO:0015986) | 3.14826249 |
| 73 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.14826249 |
| 74 | brain morphogenesis (GO:0048854) | 3.13141888 |
| 75 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.12939132 |
| 76 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.09106999 |
| 77 | nonmotile primary cilium assembly (GO:0035058) | 3.08805838 |
| 78 | fatty acid homeostasis (GO:0055089) | 3.08362083 |
| 79 | postsynaptic membrane organization (GO:0001941) | 3.07633256 |
| 80 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.04722631 |
| 81 | positive regulation of protein homodimerization activity (GO:0090073) | 3.04488364 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 3.03928241 |
| 83 | anterograde synaptic vesicle transport (GO:0048490) | 3.03675759 |
| 84 | amino acid salvage (GO:0043102) | 3.03036393 |
| 85 | L-methionine salvage (GO:0071267) | 3.03036393 |
| 86 | L-methionine biosynthetic process (GO:0071265) | 3.03036393 |
| 87 | regulation of sulfur metabolic process (GO:0042762) | 3.02698359 |
| 88 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.02437200 |
| 89 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.02252903 |
| 90 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.01426789 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 2.98388101 |
| 92 | transcription from mitochondrial promoter (GO:0006390) | 2.97993018 |
| 93 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.97540550 |
| 94 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97172458 |
| 95 | gamma-aminobutyric acid transport (GO:0015812) | 2.97159481 |
| 96 | tRNA processing (GO:0008033) | 2.95244883 |
| 97 | aerobic respiration (GO:0009060) | 2.94903637 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94137118 |
| 99 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.93626262 |
| 100 | neurotransmitter secretion (GO:0007269) | 2.93253846 |
| 101 | ubiquinone metabolic process (GO:0006743) | 2.93246463 |
| 102 | establishment of protein localization to mitochondrion (GO:0072655) | 2.89533763 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 2.89413846 |
| 104 | negative regulation of mast cell activation (GO:0033004) | 2.87258090 |
| 105 | glycerophospholipid catabolic process (GO:0046475) | 2.87196712 |
| 106 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.86333275 |
| 107 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.86333275 |
| 108 | protein targeting to mitochondrion (GO:0006626) | 2.86109394 |
| 109 | tRNA modification (GO:0006400) | 2.85367599 |
| 110 | regulation of synaptic vesicle transport (GO:1902803) | 2.84210948 |
| 111 | behavioral response to ethanol (GO:0048149) | 2.83473326 |
| 112 | tRNA metabolic process (GO:0006399) | 2.83320308 |
| 113 | ethanol oxidation (GO:0006069) | 2.83177427 |
| 114 | proteasome assembly (GO:0043248) | 2.82859826 |
| 115 | protein import into peroxisome matrix (GO:0016558) | 2.81868523 |
| 116 | NAD metabolic process (GO:0019674) | 2.81835924 |
| 117 | endothelium development (GO:0003158) | 2.81395740 |
| 118 | protein localization to synapse (GO:0035418) | 2.81193737 |
| 119 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81121034 |
| 120 | gluconeogenesis (GO:0006094) | 2.79816771 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 2.78673021 |
| 122 | neuromuscular process controlling posture (GO:0050884) | 2.77758667 |
| 123 | mannosylation (GO:0097502) | 2.77393725 |
| 124 | inositol phosphate catabolic process (GO:0071545) | 2.75878500 |
| 125 | peptidyl-histidine modification (GO:0018202) | 2.75793529 |
| 126 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.75098705 |
| 127 | intracellular protein transmembrane transport (GO:0065002) | 2.75001481 |
| 128 | cysteine metabolic process (GO:0006534) | 2.75001398 |
| 129 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73736507 |
| 130 | regulation of synapse structural plasticity (GO:0051823) | 2.73592336 |
| 131 | DNA double-strand break processing (GO:0000729) | 2.72482974 |
| 132 | inositol phosphate dephosphorylation (GO:0046855) | 2.71893261 |
| 133 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.71893261 |
| 134 | alpha-linolenic acid metabolic process (GO:0036109) | 2.71395618 |
| 135 | protein localization to mitochondrion (GO:0070585) | 2.70034528 |
| 136 | aldehyde catabolic process (GO:0046185) | 2.69993895 |
| 137 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.69237583 |
| 138 | hydrogen ion transmembrane transport (GO:1902600) | 2.68779592 |
| 139 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.67762176 |
| 140 | NADH dehydrogenase complex assembly (GO:0010257) | 2.67762176 |
| 141 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.67762176 |
| 142 | short-chain fatty acid metabolic process (GO:0046459) | 2.67607747 |
| 143 | coenzyme catabolic process (GO:0009109) | 2.66560157 |
| 144 | protein-cofactor linkage (GO:0018065) | 2.66514433 |
| 145 | GMP metabolic process (GO:0046037) | 2.65595592 |
| 146 | DNA damage response, detection of DNA damage (GO:0042769) | 2.64645828 |
| 147 | positive regulation of mitochondrial fission (GO:0090141) | 2.64344545 |
| 148 | regulation of cell communication by electrical coupling (GO:0010649) | 2.64318278 |
| 149 | hexose biosynthetic process (GO:0019319) | 2.63108499 |
| 150 | epithelial cilium movement (GO:0003351) | 2.62071244 |
| 151 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.61432398 |
| 152 | thioester biosynthetic process (GO:0035384) | 2.60898366 |
| 153 | acyl-CoA biosynthetic process (GO:0071616) | 2.60898366 |
| 154 | proton transport (GO:0015992) | 2.60277858 |
| 155 | male meiosis I (GO:0007141) | 2.60091943 |
| 156 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.58542219 |
| 157 | protein neddylation (GO:0045116) | 2.57280165 |
| 158 | locomotory exploration behavior (GO:0035641) | 2.57025162 |
| 159 | hydrogen transport (GO:0006818) | 2.56785310 |
| 160 | glyoxylate metabolic process (GO:0046487) | 2.54843015 |
| 161 | regulation of microtubule-based movement (GO:0060632) | 2.54803828 |
| 162 | presynaptic membrane assembly (GO:0097105) | 2.53893276 |
| 163 | regulation of action potential (GO:0098900) | 2.53358613 |
| 164 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.53163949 |
| 165 | proline transport (GO:0015824) | 2.52558344 |
| 166 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.52487823 |
| 167 | activation of protein kinase A activity (GO:0034199) | 2.50928741 |
| 168 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.49543199 |
| 169 | S-adenosylmethionine metabolic process (GO:0046500) | 2.49250596 |
| 170 | branched-chain amino acid catabolic process (GO:0009083) | 2.48189538 |
| 171 | ketone body metabolic process (GO:1902224) | 2.47634811 |
| 172 | glutamate metabolic process (GO:0006536) | 2.47533951 |
| 173 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.47474054 |
| 174 | fatty acid catabolic process (GO:0009062) | 2.46587320 |
| 175 | peptidyl-cysteine modification (GO:0018198) | 2.46486608 |
| 176 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.46294094 |
| 177 | tricarboxylic acid metabolic process (GO:0072350) | 2.45867452 |
| 178 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.45840936 |
| 179 | inner mitochondrial membrane organization (GO:0007007) | 2.45013342 |
| 180 | monosaccharide biosynthetic process (GO:0046364) | 2.44084436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.09217331 |
| 2 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.16472850 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.86340894 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.37146617 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.35988400 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.21032919 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03125518 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.88846197 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65359469 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.45764850 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.39915802 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.39571280 |
| 13 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39038001 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.34023911 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.28576332 |
| 16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.28494877 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.28392895 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.27163532 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18920038 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17845838 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09652851 |
| 22 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.01379879 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.99011441 |
| 24 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.98275904 |
| 25 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93317575 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.92684653 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91663821 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83594150 |
| 29 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.74572377 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71965964 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70009868 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67857078 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.67695111 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.67278477 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67055608 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.65674994 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63244233 |
| 38 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.62700659 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58057438 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57273872 |
| 41 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.54870600 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53026082 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48545976 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48470589 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47723677 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.47086555 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45456965 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45113963 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42876582 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41418604 |
| 51 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.39823527 |
| 52 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.38891539 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36693691 |
| 54 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.30966926 |
| 55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.29813753 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29680295 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29310379 |
| 58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28710009 |
| 59 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.27981457 |
| 60 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25797431 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25545873 |
| 62 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.25343157 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24187494 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23656252 |
| 65 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.23490026 |
| 66 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21502634 |
| 67 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.21481566 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21183628 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19978145 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18279973 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17777007 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.17606710 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17455753 |
| 74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17336242 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16911522 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15571072 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14684620 |
| 78 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14286054 |
| 79 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.14040228 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13320750 |
| 81 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.12650509 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12456107 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11872254 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11570223 |
| 85 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11533120 |
| 86 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.11233541 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10879526 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10393160 |
| 89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10370369 |
| 90 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10157565 |
| 91 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.09760175 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08361046 |
| 93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08237555 |
| 94 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07736948 |
| 95 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.06839271 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05976686 |
| 97 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05953715 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 1.05371362 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03427166 |
| 100 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.02607998 |
| 101 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02486812 |
| 102 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.01673849 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01321282 |
| 104 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.00796682 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00662100 |
| 106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00662100 |
| 107 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99265096 |
| 108 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97873041 |
| 109 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.97583927 |
| 110 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.96488306 |
| 111 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96313877 |
| 112 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.96023232 |
| 113 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.95442996 |
| 114 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95400041 |
| 115 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95352764 |
| 116 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95087983 |
| 117 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94489846 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94055922 |
| 119 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93550231 |
| 120 | P300_27268052_Chip-Seq_Bcells_Human | 0.93379054 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92953450 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92160592 |
| 123 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91986767 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91794506 |
| 125 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91635221 |
| 126 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91276333 |
| 127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90397777 |
| 128 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90105453 |
| 129 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89722736 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88872161 |
| 131 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88119017 |
| 132 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87692561 |
| 133 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.85994512 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84429768 |
| 135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83860105 |
| 136 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83466559 |
| 137 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.83243790 |
| 138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81169955 |
| 139 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.81024999 |
| 140 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80857016 |
| 141 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80670324 |
| 142 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.79874341 |
| 143 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79805348 |
| 144 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79583944 |
| 145 | P68_20966046_ChIP-Seq_HELA_Human | 0.79400009 |
| 146 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.79140053 |
| 147 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79112641 |
| 148 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78153944 |
| 149 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78122001 |
| 150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.76787047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.92014068 |
| 2 | MP0003880_abnormal_central_pattern | 4.51634197 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.47158593 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.37793176 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.22491415 |
| 6 | MP0001986_abnormal_taste_sensitivity | 2.92376152 |
| 7 | MP0000751_myopathy | 2.82688271 |
| 8 | MP0003787_abnormal_imprinting | 2.82533595 |
| 9 | MP0004130_abnormal_muscle_cell | 2.68181948 |
| 10 | MP0005646_abnormal_pituitary_gland | 2.59355587 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.57483576 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.54459761 |
| 13 | MP0003186_abnormal_redox_activity | 2.42285165 |
| 14 | MP0004133_heterotaxia | 2.38852054 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.27761256 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.24584868 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.23817948 |
| 18 | MP0009840_abnormal_foam_cell | 2.20264675 |
| 19 | MP0009745_abnormal_behavioral_response | 2.18602302 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.17442452 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.16064544 |
| 22 | MP0001529_abnormal_vocalization | 2.12364106 |
| 23 | MP0002064_seizures | 2.10998758 |
| 24 | MP0003329_amyloid_beta_deposits | 2.07705273 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 2.00709432 |
| 26 | MP0002254_reproductive_system_inflammat | 2.00498195 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.99511950 |
| 28 | MP0009046_muscle_twitch | 1.95366513 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.94084614 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.89851258 |
| 31 | MP0002822_catalepsy | 1.82763163 |
| 32 | MP0002736_abnormal_nociception_after | 1.82748751 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.81836470 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.80501072 |
| 35 | MP0002272_abnormal_nervous_system | 1.79754089 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.78279338 |
| 37 | MP0004147_increased_porphyrin_level | 1.74226307 |
| 38 | MP0003879_abnormal_hair_cell | 1.73096975 |
| 39 | MP0003011_delayed_dark_adaptation | 1.72225807 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.71209522 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.71068705 |
| 42 | MP0008789_abnormal_olfactory_epithelium | 1.70859857 |
| 43 | MP0000749_muscle_degeneration | 1.68274697 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.65644795 |
| 45 | MP0008058_abnormal_DNA_repair | 1.65491968 |
| 46 | MP0008004_abnormal_stomach_pH | 1.64713543 |
| 47 | MP0003690_abnormal_glial_cell | 1.64390182 |
| 48 | MP0001440_abnormal_grooming_behavior | 1.63234044 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.61950979 |
| 50 | MP0005360_urolithiasis | 1.61219159 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.60403643 |
| 52 | MP0005083_abnormal_biliary_tract | 1.59766839 |
| 53 | MP0004270_analgesia | 1.59298521 |
| 54 | MP0005365_abnormal_bile_salt | 1.58848152 |
| 55 | MP0001984_abnormal_olfaction | 1.56499704 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.56342043 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.55947590 |
| 58 | MP0003137_abnormal_impulse_conducting | 1.50262775 |
| 59 | MP0002653_abnormal_ependyma_morphology | 1.50207324 |
| 60 | MP0000604_amyloidosis | 1.44034048 |
| 61 | MP0005253_abnormal_eye_physiology | 1.43112712 |
| 62 | MP0004924_abnormal_behavior | 1.40945804 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.40945804 |
| 64 | MP0005645_abnormal_hypothalamus_physiol | 1.40513137 |
| 65 | MP0005670_abnormal_white_adipose | 1.39952252 |
| 66 | MP0008995_early_reproductive_senescence | 1.38936299 |
| 67 | MP0000747_muscle_weakness | 1.37160310 |
| 68 | MP0003136_yellow_coat_color | 1.33824380 |
| 69 | MP0002269_muscular_atrophy | 1.33489172 |
| 70 | MP0001905_abnormal_dopamine_level | 1.31389089 |
| 71 | MP0004043_abnormal_pH_regulation | 1.31358619 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.30403257 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.29470270 |
| 74 | MP0004084_abnormal_cardiac_muscle | 1.28300934 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.26461734 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.24438258 |
| 77 | MP0005330_cardiomyopathy | 1.23420530 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.23020718 |
| 79 | MP0003718_maternal_effect | 1.22039136 |
| 80 | MP0004085_abnormal_heartbeat | 1.21507526 |
| 81 | MP0005499_abnormal_olfactory_system | 1.21366660 |
| 82 | MP0005394_taste/olfaction_phenotype | 1.21366660 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.21161363 |
| 84 | MP0002972_abnormal_cardiac_muscle | 1.20552988 |
| 85 | MP0002928_abnormal_bile_duct | 1.19022727 |
| 86 | MP0001486_abnormal_startle_reflex | 1.17855919 |
| 87 | MP0004858_abnormal_nervous_system | 1.16640744 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16062235 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 1.14660840 |
| 90 | MP0005332_abnormal_amino_acid | 1.13639284 |
| 91 | MP0003123_paternal_imprinting | 1.13121990 |
| 92 | MP0005620_abnormal_muscle_contractility | 1.13047831 |
| 93 | MP0000015_abnormal_ear_pigmentation | 1.10256945 |
| 94 | MP0002210_abnormal_sex_determination | 1.08914509 |
| 95 | MP0002106_abnormal_muscle_physiology | 1.08453728 |
| 96 | MP0003786_premature_aging | 1.07490193 |
| 97 | MP0001485_abnormal_pinna_reflex | 1.07399417 |
| 98 | MP0008260_abnormal_autophagy | 1.04478500 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 1.04337692 |
| 100 | MP0002067_abnormal_sensory_capabilities | 1.04316443 |
| 101 | MP0003121_genomic_imprinting | 1.04306705 |
| 102 | MP0002735_abnormal_chemical_nociception | 1.03196566 |
| 103 | MP0005389_reproductive_system_phenotype | 1.03159932 |
| 104 | MP0003303_peritoneal_inflammation | 1.02853439 |
| 105 | MP0000013_abnormal_adipose_tissue | 1.02795429 |
| 106 | MP0001970_abnormal_pain_threshold | 1.02794796 |
| 107 | MP0010386_abnormal_urinary_bladder | 1.01544925 |
| 108 | MP0002160_abnormal_reproductive_system | 1.00592194 |
| 109 | MP0000778_abnormal_nervous_system | 0.99702572 |
| 110 | MP0004885_abnormal_endolymph | 0.99122243 |
| 111 | MP0003698_abnormal_male_reproductive | 0.97659296 |
| 112 | MP0002734_abnormal_mechanical_nocicepti | 0.97489336 |
| 113 | MP0008569_lethality_at_weaning | 0.97409733 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97385027 |
| 115 | MP0004142_abnormal_muscle_tone | 0.97331226 |
| 116 | MP0005266_abnormal_metabolism | 0.97222647 |
| 117 | MP0002229_neurodegeneration | 0.96638386 |
| 118 | MP0008775_abnormal_heart_ventricle | 0.96478483 |
| 119 | MP0000358_abnormal_cell_content/ | 0.96132451 |
| 120 | MP0002066_abnormal_motor_capabilities/c | 0.95449424 |
| 121 | MP0005535_abnormal_body_temperature | 0.95379680 |
| 122 | MP0001929_abnormal_gametogenesis | 0.94718463 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.93691938 |
| 124 | MP0000427_abnormal_hair_cycle | 0.93510996 |
| 125 | MP0005423_abnormal_somatic_nervous | 0.91804496 |
| 126 | MP0001544_abnormal_cardiovascular_syste | 0.90798488 |
| 127 | MP0005385_cardiovascular_system_phenoty | 0.90798488 |
| 128 | MP0003938_abnormal_ear_development | 0.90514134 |
| 129 | MP0008874_decreased_physiological_sensi | 0.90351177 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.89351336 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.88892803 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.88577647 |
| 133 | MP0003191_abnormal_cellular_cholesterol | 0.87464112 |
| 134 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87377369 |
| 135 | MP0004233_abnormal_muscle_weight | 0.87271934 |
| 136 | MP0001944_abnormal_pancreas_morphology | 0.87180408 |
| 137 | MP0005369_muscle_phenotype | 0.86999628 |
| 138 | MP0003633_abnormal_nervous_system | 0.85844923 |
| 139 | MP0005220_abnormal_exocrine_pancreas | 0.85584432 |
| 140 | MP0008872_abnormal_physiological_respon | 0.84341014 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.83969581 |
| 142 | MP0001853_heart_inflammation | 0.83044918 |
| 143 | MP0001756_abnormal_urination | 0.82329814 |
| 144 | MP0002102_abnormal_ear_morphology | 0.81252074 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.80897497 |
| 146 | MP0008877_abnormal_DNA_methylation | 0.80636181 |
| 147 | MP0008007_abnormal_cellular_replicative | 0.80275111 |
| 148 | MP0002095_abnormal_skin_pigmentation | 0.79834609 |
| 149 | MP0001145_abnormal_male_reproductive | 0.79088994 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.78258502 |
| 151 | MP0009697_abnormal_copulation | 0.78143543 |
| 152 | MP0009643_abnormal_urine_homeostasis | 0.76300444 |
| 153 | MP0003172_abnormal_lysosome_physiology | 0.76020488 |
| 154 | MP0002069_abnormal_eating/drinking_beha | 0.75578830 |
| 155 | MP0001764_abnormal_homeostasis | 0.75177682 |
| 156 | MP0003631_nervous_system_phenotype | 0.74103057 |
| 157 | MP0000750_abnormal_muscle_regeneration | 0.73747851 |
| 158 | MP0005319_abnormal_enzyme/_coenzyme | 0.71141828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.20246636 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.14430363 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.01559046 |
| 4 | Myokymia (HP:0002411) | 3.94269265 |
| 5 | Hepatic necrosis (HP:0002605) | 3.89730749 |
| 6 | Focal motor seizures (HP:0011153) | 3.89197544 |
| 7 | Neuroendocrine neoplasm (HP:0100634) | 3.85870271 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.81056023 |
| 9 | Abnormality of glycolysis (HP:0004366) | 3.81056023 |
| 10 | Pheochromocytoma (HP:0002666) | 3.80614690 |
| 11 | Acute encephalopathy (HP:0006846) | 3.71474434 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.66304950 |
| 13 | Broad alveolar ridges (HP:0000187) | 3.49405497 |
| 14 | Increased CSF lactate (HP:0002490) | 3.45011397 |
| 15 | Esophageal neoplasm (HP:0100751) | 3.44502182 |
| 16 | Neoplasm of head and neck (HP:0012288) | 3.44502182 |
| 17 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35000854 |
| 18 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28393075 |
| 19 | Atonic seizures (HP:0010819) | 3.23643787 |
| 20 | Progressive macrocephaly (HP:0004481) | 3.21799225 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17160604 |
| 22 | Cerebral edema (HP:0002181) | 3.14990331 |
| 23 | Nephronophthisis (HP:0000090) | 3.13054014 |
| 24 | Pancreatic cysts (HP:0001737) | 3.06531074 |
| 25 | Hyperventilation (HP:0002883) | 3.04195641 |
| 26 | Tubulointerstitial nephritis (HP:0001970) | 3.03482095 |
| 27 | Atrioventricular block (HP:0001678) | 2.98864126 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 2.96103258 |
| 29 | Lactic acidosis (HP:0003128) | 2.91444430 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.88968849 |
| 31 | True hermaphroditism (HP:0010459) | 2.86726179 |
| 32 | Pancreatic fibrosis (HP:0100732) | 2.85691839 |
| 33 | Renal Fanconi syndrome (HP:0001994) | 2.84664879 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 2.82117377 |
| 35 | Hyperalaninemia (HP:0003348) | 2.82117377 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.82117377 |
| 37 | Abnormality of the renal medulla (HP:0100957) | 2.75405440 |
| 38 | Medial flaring of the eyebrow (HP:0010747) | 2.74687034 |
| 39 | Exercise-induced myalgia (HP:0003738) | 2.70037447 |
| 40 | Type II lissencephaly (HP:0007260) | 2.68747036 |
| 41 | Epileptic encephalopathy (HP:0200134) | 2.68395424 |
| 42 | Febrile seizures (HP:0002373) | 2.66868223 |
| 43 | Exercise-induced muscle cramps (HP:0003710) | 2.66056741 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.65844485 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.65844485 |
| 46 | Microvesicular hepatic steatosis (HP:0001414) | 2.65087670 |
| 47 | Exercise intolerance (HP:0003546) | 2.64307542 |
| 48 | Myoglobinuria (HP:0002913) | 2.61937371 |
| 49 | Increased serum lactate (HP:0002151) | 2.58788914 |
| 50 | Ragged-red muscle fibers (HP:0003200) | 2.58771045 |
| 51 | Focal seizures (HP:0007359) | 2.57149362 |
| 52 | Methylmalonic aciduria (HP:0012120) | 2.49434285 |
| 53 | Respiratory failure (HP:0002878) | 2.49429703 |
| 54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48627858 |
| 55 | Ketoacidosis (HP:0001993) | 2.48186304 |
| 56 | Visual hallucinations (HP:0002367) | 2.47517226 |
| 57 | CNS demyelination (HP:0007305) | 2.46467792 |
| 58 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.46442687 |
| 59 | Heart block (HP:0012722) | 2.45456602 |
| 60 | Increased hepatocellular lipid droplets (HP:0006565) | 2.45272983 |
| 61 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.45253416 |
| 62 | Hyperammonemia (HP:0001987) | 2.43052780 |
| 63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.41409258 |
| 64 | Chronic hepatic failure (HP:0100626) | 2.40867056 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.40692713 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.38392919 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.35621755 |
| 68 | Concave nail (HP:0001598) | 2.33112367 |
| 69 | Hypoplastic left heart (HP:0004383) | 2.32056228 |
| 70 | Ketosis (HP:0001946) | 2.30097051 |
| 71 | Cholelithiasis (HP:0001081) | 2.27460131 |
| 72 | Absence seizures (HP:0002121) | 2.27408226 |
| 73 | Palpitations (HP:0001962) | 2.24227523 |
| 74 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.22723733 |
| 75 | Pendular nystagmus (HP:0012043) | 2.22486569 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.21616491 |
| 77 | Cholecystitis (HP:0001082) | 2.21616491 |
| 78 | Respiratory difficulties (HP:0002880) | 2.20470922 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 2.19949188 |
| 80 | Hypoalphalipoproteinemia (HP:0003233) | 2.19276533 |
| 81 | Lethargy (HP:0001254) | 2.18555621 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18302435 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.18193006 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18193006 |
| 85 | Cystic liver disease (HP:0006706) | 2.18147559 |
| 86 | Delayed CNS myelination (HP:0002188) | 2.17503422 |
| 87 | Abnormality of the lower motor neuron (HP:0002366) | 2.16819045 |
| 88 | Nephrogenic diabetes insipidus (HP:0009806) | 2.16520281 |
| 89 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.15761174 |
| 90 | Paraparesis (HP:0002385) | 2.15423103 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 2.14336420 |
| 92 | Congenital primary aphakia (HP:0007707) | 2.14280465 |
| 93 | Sclerocornea (HP:0000647) | 2.13915684 |
| 94 | Emotional lability (HP:0000712) | 2.13813044 |
| 95 | Gait imbalance (HP:0002141) | 2.13542864 |
| 96 | Oligomenorrhea (HP:0000876) | 2.13154218 |
| 97 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13148880 |
| 98 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.13074300 |
| 99 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.13074300 |
| 100 | Congenital hepatic fibrosis (HP:0002612) | 2.10805700 |
| 101 | Anxiety (HP:0000739) | 2.09818832 |
| 102 | Leukodystrophy (HP:0002415) | 2.09477149 |
| 103 | Polyphagia (HP:0002591) | 2.09262634 |
| 104 | Epiphyseal stippling (HP:0010655) | 2.08805294 |
| 105 | Agitation (HP:0000713) | 2.08782030 |
| 106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.08117473 |
| 107 | Abnormality of glycine metabolism (HP:0010895) | 2.08117473 |
| 108 | Poor suck (HP:0002033) | 2.06922325 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.06718991 |
| 110 | Thyroid-stimulating hormone excess (HP:0002925) | 2.06434604 |
| 111 | Dialeptic seizures (HP:0011146) | 2.06194771 |
| 112 | Calf muscle hypertrophy (HP:0008981) | 2.06059667 |
| 113 | Tetraparesis (HP:0002273) | 2.06005157 |
| 114 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.05540756 |
| 115 | Aplasia of the phalanges of the hand (HP:0009802) | 2.05540756 |
| 116 | Aplasia involving bones of the extremities (HP:0009825) | 2.05540756 |
| 117 | Sudden death (HP:0001699) | 2.05442297 |
| 118 | Fetal akinesia sequence (HP:0001989) | 2.05247235 |
| 119 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.05018150 |
| 120 | Abnormal drinking behavior (HP:0030082) | 2.04309754 |
| 121 | Polydipsia (HP:0001959) | 2.04309754 |
| 122 | Retinal dysplasia (HP:0007973) | 2.03948521 |
| 123 | Broad-based gait (HP:0002136) | 2.03849962 |
| 124 | Dry hair (HP:0011359) | 2.03392006 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.03044657 |
| 126 | Generalized tonic-clonic seizures (HP:0002069) | 2.02270817 |
| 127 | Poor eye contact (HP:0000817) | 2.01897240 |
| 128 | Neoplasm of the adrenal gland (HP:0100631) | 2.01307138 |
| 129 | Severe visual impairment (HP:0001141) | 2.01081591 |
| 130 | Tinnitus (HP:0000360) | 2.00998090 |
| 131 | Brushfield spots (HP:0001088) | 2.00816231 |
| 132 | Hyperglycinemia (HP:0002154) | 2.00584361 |
| 133 | Renal cortical cysts (HP:0000803) | 1.99563525 |
| 134 | Abnormality of the alveolar ridges (HP:0006477) | 1.97580577 |
| 135 | Ankle clonus (HP:0011448) | 1.97037033 |
| 136 | Gout (HP:0001997) | 1.96884508 |
| 137 | Inability to walk (HP:0002540) | 1.96784854 |
| 138 | Abnormality of renal resorption (HP:0011038) | 1.96349721 |
| 139 | Tubular atrophy (HP:0000092) | 1.96304700 |
| 140 | Hyperglycinuria (HP:0003108) | 1.96005263 |
| 141 | Impaired social interactions (HP:0000735) | 1.94918246 |
| 142 | Abnormal social behavior (HP:0012433) | 1.94918246 |
| 143 | Testicular neoplasm (HP:0010788) | 1.94814591 |
| 144 | Type I transferrin isoform profile (HP:0003642) | 1.93364135 |
| 145 | Optic disc pallor (HP:0000543) | 1.93338682 |
| 146 | Exertional dyspnea (HP:0002875) | 1.91702516 |
| 147 | Congenital stationary night blindness (HP:0007642) | 1.89622038 |
| 148 | Progressive microcephaly (HP:0000253) | 1.89295044 |
| 149 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88819056 |
| 150 | Opisthotonus (HP:0002179) | 1.88696514 |
| 151 | Prolonged QT interval (HP:0001657) | 1.87126068 |
| 152 | CNS hypomyelination (HP:0003429) | 1.86123014 |
| 153 | Hypomagnesemia (HP:0002917) | 1.85347106 |
| 154 | Metabolic acidosis (HP:0001942) | 1.84301557 |
| 155 | Severe muscular hypotonia (HP:0006829) | 1.84040076 |
| 156 | Poor speech (HP:0002465) | 1.84028383 |
| 157 | Attenuation of retinal blood vessels (HP:0007843) | 1.81912683 |
| 158 | Bile duct proliferation (HP:0001408) | 1.81702771 |
| 159 | Abnormal biliary tract physiology (HP:0012439) | 1.81702771 |
| 160 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.79758833 |
| 161 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.78904605 |
| 162 | Intestinal atresia (HP:0011100) | 1.78336600 |
| 163 | Tubulointerstitial abnormality (HP:0001969) | 1.74899590 |
| 164 | Polyuria (HP:0000103) | 1.74231560 |
| 165 | Limb hypertonia (HP:0002509) | 1.73339497 |
| 166 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.73086970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 5.23011628 |
| 2 | MAPKAPK3 | 4.82644990 |
| 3 | MAP4K2 | 3.19903430 |
| 4 | MAP3K12 | 3.16557840 |
| 5 | DAPK1 | 3.03643211 |
| 6 | VRK2 | 2.98146336 |
| 7 | WNK4 | 2.77951852 |
| 8 | MAPKAPK5 | 2.39170949 |
| 9 | PDK3 | 2.36436665 |
| 10 | PDK4 | 2.36436665 |
| 11 | MAP2K6 | 2.31007776 |
| 12 | DAPK2 | 2.14258427 |
| 13 | MAP3K11 | 2.12527527 |
| 14 | MAPK13 | 2.10903969 |
| 15 | MAPK12 | 2.08861129 |
| 16 | EPHA4 | 2.08571291 |
| 17 | CDK19 | 2.08026425 |
| 18 | FRK | 2.07378544 |
| 19 | INSRR | 2.00536733 |
| 20 | CCNB1 | 1.97086204 |
| 21 | PRPF4B | 1.96524931 |
| 22 | RPS6KA2 | 1.96515330 |
| 23 | GRK1 | 1.95201828 |
| 24 | BCKDK | 1.88863995 |
| 25 | MAP3K4 | 1.80997845 |
| 26 | MAP2K7 | 1.79393173 |
| 27 | TSSK6 | 1.78181394 |
| 28 | CASK | 1.78144131 |
| 29 | TLK1 | 1.78079663 |
| 30 | TAOK3 | 1.72653606 |
| 31 | ZAK | 1.70331936 |
| 32 | MAP3K6 | 1.68197764 |
| 33 | TNK2 | 1.67862159 |
| 34 | MYLK | 1.65741333 |
| 35 | NUAK1 | 1.63105234 |
| 36 | KDR | 1.51374792 |
| 37 | PRKCG | 1.42510055 |
| 38 | EIF2AK1 | 1.41184824 |
| 39 | MINK1 | 1.36930171 |
| 40 | DYRK2 | 1.33863117 |
| 41 | VRK1 | 1.32479255 |
| 42 | NTRK3 | 1.29232126 |
| 43 | ARAF | 1.27453278 |
| 44 | PDK2 | 1.26795974 |
| 45 | PINK1 | 1.24949763 |
| 46 | PHKG1 | 1.24798959 |
| 47 | PHKG2 | 1.24798959 |
| 48 | MARK1 | 1.22564099 |
| 49 | NEK1 | 1.22147214 |
| 50 | CAMK1D | 1.20622796 |
| 51 | NME1 | 1.15752777 |
| 52 | CAMKK2 | 1.14233819 |
| 53 | NTRK2 | 1.12765297 |
| 54 | TAOK2 | 1.11778595 |
| 55 | MAP4K1 | 1.11166750 |
| 56 | BRSK1 | 1.08101844 |
| 57 | MAPK7 | 1.05629732 |
| 58 | SCYL2 | 1.03875428 |
| 59 | TESK1 | 1.03700504 |
| 60 | ZAP70 | 1.02046201 |
| 61 | LMTK2 | 1.01157823 |
| 62 | PRKCI | 1.00795514 |
| 63 | MAP3K9 | 0.98790947 |
| 64 | MAP2K4 | 0.98473353 |
| 65 | ADRBK1 | 0.97573159 |
| 66 | RPS6KB2 | 0.95652924 |
| 67 | STK16 | 0.95304859 |
| 68 | RPS6KC1 | 0.94322328 |
| 69 | RPS6KL1 | 0.94322328 |
| 70 | MAP2K3 | 0.93568445 |
| 71 | DAPK3 | 0.92775722 |
| 72 | TRPM7 | 0.92704661 |
| 73 | PTK2B | 0.92549494 |
| 74 | BMPR1B | 0.92017628 |
| 75 | RPS6KB1 | 0.92017088 |
| 76 | SGK2 | 0.87705724 |
| 77 | RPS6KA6 | 0.83150138 |
| 78 | MAP2K2 | 0.81763355 |
| 79 | IKBKB | 0.81589721 |
| 80 | TAF1 | 0.80651601 |
| 81 | SGK494 | 0.80643216 |
| 82 | SGK223 | 0.80643216 |
| 83 | CSNK1G1 | 0.77952885 |
| 84 | MAPK11 | 0.77929160 |
| 85 | PIM2 | 0.77251442 |
| 86 | PASK | 0.77102758 |
| 87 | ITK | 0.73456696 |
| 88 | STK39 | 0.73318873 |
| 89 | CSNK1G2 | 0.73189268 |
| 90 | OXSR1 | 0.72756431 |
| 91 | FES | 0.72653514 |
| 92 | MAP3K5 | 0.72582866 |
| 93 | CAMKK1 | 0.72350003 |
| 94 | OBSCN | 0.71494671 |
| 95 | MARK3 | 0.71105295 |
| 96 | CDK5 | 0.70476910 |
| 97 | RPS6KA5 | 0.69581908 |
| 98 | TEC | 0.66727449 |
| 99 | PRKD3 | 0.66484137 |
| 100 | CAMK2B | 0.66203166 |
| 101 | GRK7 | 0.66187834 |
| 102 | BRAF | 0.65933741 |
| 103 | CAMK1 | 0.65045176 |
| 104 | TTN | 0.64721346 |
| 105 | CDK18 | 0.62941253 |
| 106 | WNK3 | 0.61977303 |
| 107 | ATR | 0.61267878 |
| 108 | CSNK1G3 | 0.60683877 |
| 109 | CDK15 | 0.58531145 |
| 110 | CSNK1A1L | 0.57341440 |
| 111 | CAMK2A | 0.56670111 |
| 112 | TYRO3 | 0.55941973 |
| 113 | CAMK1G | 0.55163032 |
| 114 | FGFR2 | 0.54953147 |
| 115 | IRAK1 | 0.54626288 |
| 116 | CDK11A | 0.53614614 |
| 117 | TNIK | 0.53227697 |
| 118 | SIK2 | 0.53045096 |
| 119 | STK11 | 0.52765055 |
| 120 | SGK3 | 0.52043193 |
| 121 | RAF1 | 0.51684082 |
| 122 | PRKCZ | 0.51396556 |
| 123 | CSNK1A1 | 0.50251402 |
| 124 | BTK | 0.49851618 |
| 125 | MAPK4 | 0.49191191 |
| 126 | DYRK1A | 0.49085356 |
| 127 | UHMK1 | 0.46785120 |
| 128 | PAK4 | 0.46677011 |
| 129 | CDK14 | 0.45485327 |
| 130 | ADRBK2 | 0.45311030 |
| 131 | LIMK1 | 0.45134527 |
| 132 | DYRK3 | 0.44822222 |
| 133 | CAMK2G | 0.43550914 |
| 134 | MAPK15 | 0.43321618 |
| 135 | PLK2 | 0.42567971 |
| 136 | MST4 | 0.42431625 |
| 137 | AKT3 | 0.41922250 |
| 138 | PNCK | 0.41252821 |
| 139 | PRKCE | 0.39903899 |
| 140 | KSR2 | 0.39669718 |
| 141 | PDK1 | 0.38952016 |
| 142 | ILK | 0.38409358 |
| 143 | ALK | 0.37500564 |
| 144 | TIE1 | 0.37072416 |
| 145 | ATM | 0.36883198 |
| 146 | BRSK2 | 0.34790862 |
| 147 | WEE1 | 0.34682063 |
| 148 | GRK5 | 0.34249990 |
| 149 | CAMK4 | 0.33706463 |
| 150 | PLK3 | 0.33591126 |
| 151 | PRKAA1 | 0.33578575 |
| 152 | LYN | 0.33220494 |
| 153 | IRAK2 | 0.32936765 |
| 154 | FGFR4 | 0.32306704 |
| 155 | PRKACA | 0.32019640 |
| 156 | TGFBR1 | 0.31713822 |
| 157 | SYK | 0.31019727 |
| 158 | PAK3 | 0.30787814 |
| 159 | BCR | 0.30753059 |
| 160 | PDPK1 | 0.30268342 |
| 161 | CHUK | 0.30154573 |
| 162 | TXK | 0.29892649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.91763598 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.97352881 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.76774024 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.04509516 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.77953499 |
| 6 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.56107387 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.50669386 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.44256385 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40539929 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.35387246 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.33923376 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.11716959 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.09144412 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.06146322 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.00181289 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00162768 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.96258736 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.88182761 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88181511 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.87845019 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.81993427 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81740463 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.81326985 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.78934073 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.76477308 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.73119998 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.72374553 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64386983 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.63522880 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62602947 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60968506 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59479687 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57989467 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.57684504 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55576383 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.51669231 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49601715 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.47134056 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.46570827 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.46148674 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45486429 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.41760993 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.41507178 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41092413 |
| 45 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40350299 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.37215730 |
| 47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.26981044 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.18344327 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.17608275 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.17319411 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16700070 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.16239879 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16093954 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13793424 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12479360 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10717694 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10649770 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10133952 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.08902300 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07303650 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06853148 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05728901 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05447823 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 1.01674436 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98551315 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.97978507 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97403453 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96010737 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94837094 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94064439 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93846847 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88848240 |
| 73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87500799 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84875633 |
| 75 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83790432 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83642643 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82810028 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80675156 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74936500 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73805503 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72886354 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71562317 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69255312 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67354992 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66217479 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.66196263 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65894977 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65732834 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64533493 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.62981674 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58834430 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58279947 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.57563558 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57350876 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56013627 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55656121 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55642237 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.53598659 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.53561285 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53546391 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52587285 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51985404 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.50912387 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50330737 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48963179 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.47929815 |
| 107 | DNA replication_Homo sapiens_hsa03030 | 0.45321816 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45146605 |
| 109 | Spliceosome_Homo sapiens_hsa03040 | 0.44937465 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.44652543 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43969746 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43589207 |
| 113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43489397 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.43349890 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43000913 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42574695 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42425083 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42381706 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41997367 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41973154 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41659972 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41440184 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40983088 |
| 124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40879007 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40490442 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40340872 |
| 127 | Mismatch repair_Homo sapiens_hsa03430 | 0.39775929 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39570097 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38765751 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37411367 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36855387 |
| 132 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36491583 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35325651 |
| 134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34233868 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33849715 |
| 136 | Purine metabolism_Homo sapiens_hsa00230 | 0.32760882 |
| 137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32752076 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32486796 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31792734 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31091923 |
| 141 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30159528 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29417589 |
| 143 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27125808 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26962757 |
| 145 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26933055 |
| 146 | RNA polymerase_Homo sapiens_hsa03020 | 0.26278518 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24879290 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24606585 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24001618 |
| 150 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23806726 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21087269 |

